During the recent session, 2seventy bio Inc (NASDAQ:TSVT)’s traded shares were 0.84 million, with the beta value of the company hitting 1.90. At the last check today, the stock’s price was $3.67, reflecting an intraday loss of -13.93% or -$0.6. The 52-week high for the TSVT share is $12.69, that puts it down -245.78 from that peak though still a striking 58.31% gain since the share price plummeted to a 52-week low of $1.53. The company’s market capitalization is $188.56M, and the average trade volume was 1.44 million shares over the past three months.
2seventy bio Inc (NASDAQ:TSVT) trade information
2seventy bio Inc (TSVT) registered a -13.93% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -13.93% in intraday trading to $3.67, hitting a weekly high. The stock’s 5-day price performance is -20.80%, and it has moved by -25.91% in 30 days. Based on these gigs, the overall price performance for the year is -57.17%.
2seventy bio Inc (TSVT) estimates and forecasts
Statistics show that 2seventy bio Inc has outperformed its competitors in share price, compared to the industry in which it operates. 2seventy bio Inc (TSVT) shares have gone down -1.47% during the last six months, with a year-to-date growth rate more than the industry average at 68.55% against 12.90. In the rating firms’ projections, revenue will decrease -21.70% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 13.94M as predicted by 6 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to 17M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 22.3M and 36.05M respectively. In this case, analysts expect current quarter sales to shrink by -37.50% and then drop by -52.80% in the coming quarter.
While earnings are projected to return 56.00% in 2024.
TSVT Dividends
2seventy bio Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
